Global Cancer Vaccines Market Overview:
Global Cancer Vaccines Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2025-2032, Considering the Base Year As 2024.
Global Cancer Vaccines Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Cancer Vaccines involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Cancer Vaccines Market:
The Cancer Vaccines Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Cancer Vaccines Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Cancer Vaccines Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Cancer Vaccines market has been segmented into:
Preventive Vaccine
Therapeutic Vaccine
Other Vaccine Types
By Application, Cancer Vaccines market has been segmented into:
Recombinant Technology
Viral Vector & DNA Technology
Whole-Cell Technology
Other Technologies
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Cancer Vaccines market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Cancer Vaccines market.
Top Key Players Covered in Cancer Vaccines market are:
Agenus Inc.
Astellas Pharma Inc.
AstraZeneca PLC
Bristol-Myers Squibb Company
Celldex Therapeutics Inc.
F. Hoffmann-La Roche Ltd
Genexine Inc.
Gritstone bio
ImmunityBio Inc.
Immutep Ltd
ISA Pharmaceuticals B.V.
Merck & Co. Inc.
Northwest Biotherapeutics Inc.
OncBioMune Pharmaceuticals Inc.
Oncovir Inc.
Pfizer Inc.
Sanofi SA
Serum Institute of India Pvt. Ltd.
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Cancer Vaccines Market Type
4.1 Cancer Vaccines Market Snapshot and Growth Engine
4.2 Cancer Vaccines Market Overview
4.3 Preventive Vaccine
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Preventive Vaccine: Geographic Segmentation Analysis
4.4 Therapeutic Vaccine
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Therapeutic Vaccine: Geographic Segmentation Analysis
4.5 Other Vaccine Types
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Other Vaccine Types: Geographic Segmentation Analysis
Chapter 5: Cancer Vaccines Market Application
5.1 Cancer Vaccines Market Snapshot and Growth Engine
5.2 Cancer Vaccines Market Overview
5.3 Recombinant Technology
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Recombinant Technology: Geographic Segmentation Analysis
5.4 Viral Vector & DNA Technology
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Viral Vector & DNA Technology: Geographic Segmentation Analysis
5.5 Whole-Cell Technology
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Whole-Cell Technology: Geographic Segmentation Analysis
5.6 Other Technologies
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 Other Technologies: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Cancer Vaccines Market Share by Manufacturer (2025)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 AGENUS INC.; ASTELLAS PHARMA INC.; ASTRAZENECA PLC; BRISTOL-MYERS SQUIBB COMPANY; CELLDEX THERAPEUTICS INC.; F. HOFFMANN-LA ROCHE LTD; GENEXINE INC.; GRITSTONE BIO; IMMUNITYBIO
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 INC.; IMMUTEP LTD; ISA PHARMACEUTICALS B.V.; MERCK & CO. INC.; NORTHWEST BIOTHERAPEUTICS INC.; ONCBIOMUNE PHARMACEUTICALS INC.; ONCOVIR INC.; PFIZER INC.; SANOFI SA; SERUM INSTITUTE OF INDIA PVT. LTD.
Chapter 7: Global Cancer Vaccines Market By Region
7.1 Overview
7.2. North America Cancer Vaccines Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Preventive Vaccine
7.2.2.2 Therapeutic Vaccine
7.2.2.3 Other Vaccine Types
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Recombinant Technology
7.2.3.2 Viral Vector & DNA Technology
7.2.3.3 Whole-Cell Technology
7.2.3.4 Other Technologies
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Cancer Vaccines Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Preventive Vaccine
7.3.2.2 Therapeutic Vaccine
7.3.2.3 Other Vaccine Types
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Recombinant Technology
7.3.3.2 Viral Vector & DNA Technology
7.3.3.3 Whole-Cell Technology
7.3.3.4 Other Technologies
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Cancer Vaccines Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Preventive Vaccine
7.4.2.2 Therapeutic Vaccine
7.4.2.3 Other Vaccine Types
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Recombinant Technology
7.4.3.2 Viral Vector & DNA Technology
7.4.3.3 Whole-Cell Technology
7.4.3.4 Other Technologies
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Cancer Vaccines Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Preventive Vaccine
7.5.2.2 Therapeutic Vaccine
7.5.2.3 Other Vaccine Types
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Recombinant Technology
7.5.3.2 Viral Vector & DNA Technology
7.5.3.3 Whole-Cell Technology
7.5.3.4 Other Technologies
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Cancer Vaccines Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Preventive Vaccine
7.6.2.2 Therapeutic Vaccine
7.6.2.3 Other Vaccine Types
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Recombinant Technology
7.6.3.2 Viral Vector & DNA Technology
7.6.3.3 Whole-Cell Technology
7.6.3.4 Other Technologies
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Cancer Vaccines Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Preventive Vaccine
7.7.2.2 Therapeutic Vaccine
7.7.2.3 Other Vaccine Types
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Recombinant Technology
7.7.3.2 Viral Vector & DNA Technology
7.7.3.3 Whole-Cell Technology
7.7.3.4 Other Technologies
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Cancer Vaccines Scope:
|
Report Data
|
Cancer Vaccines Market
|
|
Cancer Vaccines Market Size in 2025
|
USD XX million
|
|
Cancer Vaccines CAGR 2025 - 2032
|
XX%
|
|
Cancer Vaccines Base Year
|
2024
|
|
Cancer Vaccines Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Agenus Inc., Astellas Pharma Inc., AstraZeneca PLC, Bristol-Myers Squibb Company, Celldex Therapeutics Inc., F. Hoffmann-La Roche Ltd, Genexine Inc., Gritstone bio, ImmunityBio Inc., Immutep Ltd, ISA Pharmaceuticals B.V., Merck & Co. Inc., Northwest Biotherapeutics Inc., OncBioMune Pharmaceuticals Inc., Oncovir Inc., Pfizer Inc., Sanofi SA, Serum Institute of India Pvt. Ltd..
|
|
Key Segments
|
By Type
Preventive Vaccine
Therapeutic Vaccine
Other Vaccine Types
By Applications
Recombinant Technology
Viral Vector & DNA Technology
Whole-Cell Technology
Other Technologies
|
